M. Saetta (Padova, Italy), G. Schultze-Werninghaus (Bochum, Germany)
Polymorphism of the cyclo-oxygenase-2 gene protects against the development of chronic obstructive pulmonary disease
P. N. Black, R. P. Young, L. Wu (Auckland, New Zealand)
|  |
Proteomic derived biomarkers for COPD are present in induced sputum
M. Imrie, R. D. Gray, G. MacGregor, D. Noble, M. Dewar, J. A. Innes, D. Porteous, A. G. (Edinburgh, United Kingdom)
| |
Changes of intermediate substrates of carbohydrate metabolism in exhaled breath condensate (EBC) during COPD development
A. E. Makarevich, J. J. Pancratova (Minsk, Belarus)
| |
Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease
Y. H. Chen, W. Z. Yao, B. Geng, Y. L. Ding, M. Lu, M. W. Zhao, C. S. Tang (Beijing, China)
| |
Relationship between COPD and polymorphisms of HO-1 and mEPH in a Southwest Chinese population
W. P. Fu, C. Sun, L. M. Dai, Y. P. Zhang (Kunming, China)
| |
Population prevalence and risk factors for chronic bronchitis in India
S. K. Jindal, D. Gupta, S. K. Katiyar, G. D‘Souza, V. K. Vijayan (Chandigarh, Delhi, Kanpur, Bangalore, India)
| |
Incidence of alpha-1-antitrypsin (α1-AT) deficiency in patients with COPD in Poland, preliminary report
P. Kuca, E. J. Campbell, J. Zielinski (Warsaw, Poland; Salt Lake City, United States Of America)
| |
Relationships between IL6 and TNF µ and disability in chronic obstructive pulmonary disease (COPD)
R. Garrod, J. Marshall, S. Fredericks, G. W. Hagan, P. W. Jones (London, United Kingdom)
| |
Plasma leakage is elevated in COPD airways
Y. Minakata, M. Nakanishi, K. Ueshima, K. Akamatsu, T. Hirano, K. Matsunaga, T. Yamagata, M. Ichinose (Wakayama, Japan)
| |
Vascular disease is related to low FEV1 in a West Indian patient population
T. A. Seemungal, C. Poon King, A. Bhowmik, G. C. Donaldson, J. A. Wedzicha (Mount Hope, Trinidad And Tobago; London, United Kingdom)
| |
Modulation of Eosinophilic airway inflammation in COPD
R. Siva, R. Green, C. E. Brightling, M. J. Shelley, I. D. Pavord (Leicester, United Kingdom)
| |
Decreased number of circulating endothelial progenitor cells in patients with emphysema
J. H. Lee, E. K. Kim, D. Oh, S. D. Lee (Seongnam, Republic Of Korea)
| |
Selection of protein expression signatures by interfacing pathophysiology and proteomics technology in smokers and never-smokers
A. Plymoth, C. G. Lofdahl, A. Ekberg-Jansson, M. Dahlback, T. E. Fehniger, G. Marko-Varga (Lund, Sweden)
| |
Epidermal growth factor receptor (EGFR) overexpression in human bronchial epithelial cells amplifies IL-8 release provoked by cigarette smoke and bacterial surrogates
K. Liu, G. Anderson, S. Bozinovski (Parkville, Australia)
| |
Helicobacter pylori seroprevalence in patients with chronic bronchitis
M. Kanbay, G. Gur, S. Akcay, U. Yilmaz (Ankara, Turkey)
| |
Polymorphisms of IL-4, IL-10, and TNF-α gene in chronic obstructive pulmonary disease
C. M. Shih, Y. L. Lee, H. L. Chiou, W. E. Chen, L. W. Hang, W. H. Hsu (Taichung, Taiwan, Province Of China)
| |
M2 allele of alpha1-antitrypsin gene and genetic susceptibility to COPD in Korean men
S. I. Cha, E. J. Kim, J. H. Park, C. H. Kim, T. H. Jung, J. Y. Park (Daegu, Republic Of Korea)
| |
The investigation of the role of interleukin (IL)-17 in COPD and asthma
B. He, W. M. Zhao, F. Sheng, J. J. Yang, F. Pei (Beijing, China)
| |
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation
D. J. Powrie, T. M. Wilkinson, G. C. Donaldson, C. M. Dawson, J. A. Wedzicha (London, United Kingdom)
| |
Multidimensional system for assessment of COPD patients. Comparison with BODE index
S. Kostianev, V. Hodgev, D. Iluchev (Plovdiv, Bulgaria)
| |